SCHEMBL933180

SCHEMBL933180

CN1CCC(OC2=[C]NCC=C2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
LRRK2 Q5S007 1/20 0.34
CHRM2 P08172 2/20 0.33
CHRM1 P11229 2/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CYP2D6 P10635 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
MAPK1 P28482 1/20 0.33
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL933995 0.92 CHRM4 (0.37) HRH3CHRM2CHRM1CHRM4CHRM5
SCHEMBL5331154 0.68 HTR2A (0.33) SMN1; SMN2MAPK1KDM4EMEN1KMT2A
SCHEMBL933509 0.65 ADRA2C (0.32) KDM4EKMT2A
SCHEMBL27460428 0.64 HRH3 (0.39) HRH3SMN1; SMN2LRRK2CHRM2CHRM1
SCHEMBL188648 0.61 HRH3 (0.63) HRH3SMN1; SMN2CHRM2CHRM1HTR1A
SCHEMBL1515384 0.60 CHRNB2 (0.45) CHRM2CHRM1CHRM4CHRM5CHRM3
SCHEMBL995078 0.60 HRH3 (0.45) HRH3SMN1; SMN2LRRK2CHRM2CHRM1
SCHEMBL14577976 0.60 HRH3 (0.67) HRH3SMN1; SMN2MAOAMAOBSCN1A
SCHEMBL3436987 0.60 SMN1; SMN2 (0.71) HRH3SMN1; SMN2CHRM2CHRM1HTR1A
SCHEMBL14892073 0.59 HRH3 (0.47) HRH3SMN1; SMN2LRRK2CHRM4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451802-A1 PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY Pathway Therapeutics, Inc. (US) 2012-05-16 EP disclosed
WO-2011005119-A1 PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY PATHWAY THERAPEUTICS LIMITED (NZ) 2011-01-13 WO disclosed